サンプル依頼リスト カート
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：治療用ボツリヌス毒素の世界市場の分析：Medtech 360
市場調査レポート
商品コード
1419276

治療用ボツリヌス毒素の世界市場の分析：Medtech 360

Therapeutic Botulinum Toxin | Medtech 360 | Market Insights | Global
出版日: | 発行: Clarivate | ページ情報: 英文 | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
治療用ボツリヌス毒素の世界市場の分析：Medtech 360
出版日: 2023年11月22日
発行: Clarivate
ページ情報: 英文
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の治療用ボツリヌス毒素 (BTX) の処置件数、ひいては製品の販売と収益は、既存患者がメンテナンスのために再来院する必要性と、適応拡大による新規患者の需要増加によって維持されると考えられています。

当レポートでは、世界各地 (米国、欧州、アジア太平洋) の治療用ボツリヌス毒素の市場について分析し、全体的な市場動向の見通し (2019年～2032年) や、地域別の詳細動向、主な市場促進・抑制要因、昨今の市場の主な傾向などを調査しております。

目次

世界

概要

エグゼクティブサマリー

主要レポートの更新

世界の治療用ボツリヌス毒素市場

  • 市場概要
  • 市場の定義
  • 市場予測データ
  • 市場シェア
  • 競合の考察
    • Allergan (an AbbVie company)
    • Merz Pharma
    • Ipsen
    • GlaxoSmithKline
    • Supernus Pharmaceuticals
    • その他の主要な競合企業
    • すべての競合企業に影響する要因
  • 市場動向

米国の治療用ボツリヌス毒素市場

  • 市場概要
  • 市場の定義
  • 市場予測データ
  • 市場シェア
  • 競合の考察
    • 米国の治療用ボツリヌス毒素市場の競合考察
    • すべての競合企業に影響する要因

欧州の治療用ボツリヌス毒素市場

  • 市場概要
  • 市場の定義
  • 市場予測データ
  • 市場シェア
  • 競合の考察
    • 欧州の治療用ボツリヌス毒素市場の競合考察

アジア太平洋の治療用ボツリヌス毒素市場

  • 市場概要
  • 市場の定義
  • 市場予測データ
  • 市場シェア
  • 競合の考察
    • アジア太平洋の治療用ボツリヌス毒素市場の競合考察
    • すべての競合企業に影響する要因

付録

調査手法

目次
Product Code: 47041066

Global therapeutic BTX procedure volumes-and thus product sales and revenues-will be supported by the need for existing patients to return for maintenance procedures, as well as rising demand among new patients driven by expanding indications.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for therapeutic BTX in the US, Europe, and the Asia Pacific region from 2019 through 2032.

New indication approvals and existing indication expansions will be significant drivers in the therapeutic BTX market.

  • Which indications contribute the most to growth, and which have the largest market potential?
  • What regional differences exist regarding indication approvals?
  • Which competitors have been targeting these indications?

Global therapeutic BTX markets are becoming increasingly consolidated.

  • What are some key competitive strategies currently being leveraged or can potentially be employed to succeed in the market?
  • How do the competitive landscapes differ by region, and what considerations must companies make in particular markets?

Markets vary greatly by region in terms of size and growth, with the US market experiencing the fastest expansion globally.

  • What key drivers are contributing to each regional market's relative size and growth?
  • How does pricing vary by region, and what factors most significantly affect pricing within each market?
  • How does the reimbursement of therapeutic BTX products influence the pricing and adoption of these products across different indications and geographies?

Table of Contents

Global

Abstract

Executive Summary

  • COVID-19 Updates
  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • Geographies Covered
  • Procedures Covered
  • Products Covered

Key Report Updates

Global Therapeutic Botulinum Toxin Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
  • Market Shares
  • Competitive Insights
    • Allergan (an AbbVie company)
    • Merz Pharma
    • Ipsen
    • GlaxoSmithKline
    • Supernus Pharmaceuticals
    • Other Key Competitors
    • Factors Affecting All Competitors
  • Market Developments

US Therapeutic Botulinum Toxin Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
  • Market Shares
  • Competitive Insights
    • US Therapeutic Botulinum Toxin Market Competitive Insights
    • Factors Affecting All Competitors

European Therapeutic Botulinum Toxin Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
  • Market Shares
  • Competitive Insights
    • European Therapeutic Botulinum Toxin Market Competitive Insights

Asia Pacific Therapeutic Botulinum Toxin Market

  • Market Highlights
    • Key Content Updates
  • Market Definitions
  • Market Forecast Data
  • Market Shares
  • Competitive Insights
    • Asia Pacific Therapeutic Botulinum Toxin Market Competitive Insights
    • Factors Affecting All Competitors

Appendix

  • Abbreviations
  • Bibliography

Methodology

  • Core Country Coverage Methodology
  • Research Methodology
  • Marketrack Methodology
  • PriceTrack Methodology
  • Forecast Methodology
  • Supplemental Country Coverage Methodology
  • Base-Year Ratio Analysis
  • Market Forecasting

Tables and Figures

  • Therapeutic BTX Market, by Region, Global (USD), 2019-2032
  • Therapeutic BTX Market Landscape, Global (USD), 2022 and 2032
  • Therapeutic BTX Revenue Market Share Rankings, by Region, Global, 2022
  • Competitive Insights
  • Companies Mentioned
  • Recent Events in the Therapeutic BTX Market, Global
  • Key Clinical Trials in the Therapeutic BTX Market, Global
  • Emerging Products for the Therapeutic BTX Market, Global
  • Geographies Covered, Global
  • Average Currency Exchange Rates
  • Therapeutic BTX Procedures Covered, US
  • Approved Indications, by Brand, US, 2022/2023
  • Therapeutic BTX Procedures Covered, Europe
  • Approved Indications, by Brand, Europe, 2022/2023
  • Therapeutic BTX Procedures Covered, Asia Pacific
  • Approved Indications, by Brand, Asia Pacific, 2022/2023
  • Therapeutic BTX Product Overview, Global, 2022/2023
  • Global Therapeutic Botulinum Toxin Market Drivers
  • Global Therapeutic Botulinum Toxin Market Limiters
  • Therapeutic BTX Market, by Region, Global (USD), 2019-2032
  • Therapeutic BTX Product Overview, Global, 2022/2023
  • Mean Dosages, by Indication and Brand, Global
  • BTX Units Used per Procedure, by Indication, Global
  • BTX Product Equivalencies, by Brand
  • Approved Indications, by Brand, US, 2022/2023
  • Approved Indications, by Brand, Europe, 2022/2023
  • Approved Indications, by Brand, Asia Pacific, 2022/2023
  • Therapeutic BTX Procedures, by Indication, Global, 2019-2032
  • Therapeutic BTX Procedures, by Region, Global, 2019-2032
  • Therapeutic BTX Market, by Indication, Global (USD), 2019-2032
  • Therapeutic BTX Market, by Region, Global (USD), 2019-2032
  • Therapeutic BTX Market Growth, by Region, Global, 2022-2032
  • Therapeutic BTX Revenue Market Shares, Global, 2022
  • Therapeutic BTX Revenue Market Shares, by Region, Global, 2022
  • Allergan (an AbbVie company) Competitive Insights
  • Merz Pharma Competitive Insights
  • Ipsen Competitive Insights
  • GlaxoSmithKline Competitive Insights
  • Supernus Pharmaceuticals Competitive Insights
  • Competitive Insights for Other Key Competitors
  • Factors Affecting All Competitors
  • Recent Events in the Therapeutic BTX Market, Global
  • Key Clinical Trials in the Therapeutic BTX Market, Global
  • Emerging Products for the Therapeutic BTX Market, Global
  • US Therapeutic Botulinum Toxin Market Drivers
  • US Therapeutic Botulinum Toxin Market Limiters
  • Therapeutic BTX Market, US (USD), 2019-2032
  • Therapeutic BTX Procedures, by Indication, US, 2019-2032
  • Spasticity Therapeutic BTX Procedures, by Anatomy, US, 2019-2032
  • Spasticity Therapeutic BTX Procedures, by Age Group, US, 2019-2032
  • Overactive Bladder Therapeutic BTX Procedures, by Cause, US, 2019-2032
  • Therapeutic BTX Market, by Indication, US (USD), 2019-2032
  • Therapeutic BTX Market, US (USD), 2019-2032
  • Therapeutic BTX Revenue Market Shares, US 2022
  • Therapeutic BTX Revenue Market Shares, US, 2022
  • US Therapeutic Botulinum Toxin Market Competitive Insights
  • Factors Affecting All Competitors
  • European Therapeutic Botulinum Toxin Market Drivers
  • European Therapeutic Botulinum Toxin Market Limiters
  • Therapeutic BTX Market, by Country, Europe (USD), 2019-2032
  • Therapeutic BTX Procedures, by Indication, Europe, 2019-2032
  • Therapeutic BTX Procedures, by Country, Europe, 2019-2032
  • Therapeutic BTX Procedures, by Indication, France, 2019-2032
  • Therapeutic BTX Procedures, by Indication, Germany, 2019-2032
  • Therapeutic BTX Procedures, by Indication, Italy, 2019-2032
  • Therapeutic BTX Procedures, by Indication, Spain, 2019-2032
  • Therapeutic BTX Procedures, by Indication, UK, 2019-2032
  • Therapeutic BTX Market, by Indication, Europe (USD and EUR), 2019-2032
  • Therapeutic BTX Market, by Country, Europe (USD), 2019-2032
  • Therapeutic BTX Market, by Country, Europe (EUR and GBP), 2019-2032
  • Therapeutic BTX Market Growth, by Country, Europe, 2022-2032
  • Therapeutic BTX Market, by Indication, France (USD and EUR), 2019-2032
  • Therapeutic BTX Market, by Indication, Germany (USD and EUR), 2019-2032
  • Therapeutic BTX Market, by Indication, Italy (USD and EUR), 2019-2032
  • Therapeutic BTX Market, by Indication, Spain (USD and EUR), 2019-2032
  • Therapeutic BTX Market, by Indication, UK (USD and EUR), 2019-2032
  • Therapeutic BTX Market, by Indication, UK (GBP), 2019-2032
  • Therapeutic BTX Revenue Market Shares, Europe, 2022
  • Therapeutic BTX Revenue Market Shares, by Country, Europe, 2022
  • European Therapeutic Botulinum Toxin Market Competitive Insights
  • Asia Pacific Therapeutic Botulinum Toxin Market Drivers
  • Asia Pacific Therapeutic Botulinum Toxin Market Limiters
  • Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019-2032
  • Therapeutic BTX Procedures, by Indication, Asia Pacific, 2019-2032
  • Therapeutic BTX Procedures, by Country, Asia Pacific, 2019-2032
  • Therapeutic BTX Procedures, by Indication, Australia, 2019-2032
  • Spasticity Therapeutic BTX Procedures, by Anatomy, Australia, 2019-2032
  • Spasticity Therapeutic BTX Procedures, by Age Group, Australia, 2019-2032
  • Overactive Bladder Therapeutic BTX Procedures, by Cause, Australia, 2019-2032
  • Therapeutic BTX Procedures, by Indication, Japan, 2019-2032
  • Therapeutic BTX Market, by Indication, Asia Pacific (USD), 2019-2032
  • Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019-2032
  • Therapeutic BTX Market, by Indication, Australia (USD), 2019-2032
  • Therapeutic BTX Market, Australia (USD), 2019-2032
  • Therapeutic BTX Market, by Indication, Japan (USD), 2019-2032
  • Therapeutic BTX Market, Japan (USD), 2019-2032
  • Therapeutic BTX Revenue Market Shares, Asia Pacific, 2022
  • Therapeutic BTX Revenue Market Shares, by Country, Asia Pacific, 2022
  • Asia Pacific Therapeutic Botulinum Toxin Market Competitive Insights
  • Factors Affecting All Competitors
  • Abbreviations